-
Spurs closing in on Man City's Marmoush after signing Savio
-
Man City sign Lille's Bouaddi for 100 mn euros
-
Celtic count the cost of Champions League flop
-
Sooriyabandara, Mendis lead Sri Lanka fightback after follow-on
-
Lebanon accuses Israel of burning forest, farmland in south
-
With ropes and chants, thousands move Japanese castle
-
Nepal floods at China border kill 8, cause 'major casualties' in Tibet
-
Zurich Diamond League: five events to watch
-
France eases cow diets as cheesemakers sweat
-
'Black smoke' chokes Pakistan maternity ward as hospital fire kills 14 infants
-
America unites in mourning for Dolly Parton
-
French flight attendant wins landmark breast cancer ruling
-
Meta and US states discuss settlement in landmark social media trial: report
-
Sri Lanka 83-2 after India enforce follow-on in second Test
-
Fire haze threatens health of millions in Indonesia, ministry warns
-
Pakistan hospital fire kills 14 infants
-
Senegal-made sickle cell treatment raises hopes, reduces costs
-
Iceland to vote on resuming EU talks in close referendum
-
Iran says Hormuz strait still closed despite transit corridor talks
-
North Korea to 'bring joy' to Kim with 100 athletes at Asian Games
-
'Our patron saint': Tennesseans mourn local hero Dolly Parton
-
US LGBTQ community mourns 'diva' Dolly Parton
-
Australian police hunt thieves in $250,000 oyster heist
-
England bid to banish booze woes as Pakistan seek self-respect
-
Coordinated attacks: Thailand's southern insurgency flares
-
High quality, low risk: record number of Japanese in Premier League
-
Asian Games chiefs hold talks as participant numbers balloon
-
Stocks edge higher as oil drops on fresh Mideast hopes
-
Too small for fries: drought shrinks Belgian potatoes
-
Pakistan's girls fight for their place in the boxing ring
-
Drought-hit Danube gives way to fossil hunt in Bulgaria
-
Five things to know about Anthropic ahead of Wall Street debut
-
Julia Curlee, CIA officer fired by White House for being transgender
-
Social media use on the rise among Australian under-16s after ban: data
-
Fave or flop? A guide to gauging video game success
-
EON Resources Inc. Announces 92 Horizontal Well Drilling Program Has Begun! $1 Million Per Month Increase Anticipated in Free Cash Flow in Q4 2026
-
Who is the Best Eyelid Surgeon in Kirkland?
-
Who Does the Best Plastic Surgery in Florida?
-
How to Manage Costs for Urgent Plumbing Repairs
-
How to Fix DIY Home Improvement Regrets Months Later
-
Eagle Plains Reports Anomalous Radioactivity from First Drillholes at the Don Lake Uranium Project, Saskatchewan
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 26
-
Instagram chief admits touting teen safety tool while omitting it was barely used
-
Williams-Alcaraz fall in US Open mixed quarter-finals
-
'Final Fantasy', 'The Witcher' in spotlight at Europe gaming bash
-
Mark Carney, the former central banker who said 'no' to Trump
-
Syrian Kurdish leader dissolves force that spearheaded jihadist fight
-
Segner out of South Africa tour as New Zealand injuries pile up
-
Trump raises prospect of demolishing iconic Kennedy Center
-
Meta knew teen safety tools were ineffective, witnesses testify
BetterWay Enters Into an Affiliation Agreement with UT Austin for Capillary Blood Collection
AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a five-year clinical affiliation agreement with The University of Texas at Austin School of Nursing through the city-funded Advancing Mental Health and Emotional Nourishment (AMEN) project. Under this partnership, Babson Diagnostics will provide training in the use of its BetterWay capillary blood collection technology as an integrated component of select undergraduate nursing courses and will supervise outreach events where students perform BetterWay's fingertip collection for underserved populations. The agreement will acquaint students with important diagnostic technology as they serve their community.
To date, Babson Diagnostics has already trained 26 UT nursing students to operate its BetterWay blood collection technology-which enables accurate blood testing with a less invasive fingertip collection-as part of an existing relationship through the School of Nursing's AMEN project. Under the five-year clinical affiliation agreement, BetterWay collection tech training will be required for students enrolled in select courses, including the Public Health Nursing Practicum. In this practicum, 10 currently enrolled students have already completed the training and participated in 3 community outreach events co‑sponsored by AMEN.
"By collaborating with The University of Texas, we're able to provide the nursing workforce of tomorrow training and access to BetterWay, a modern alternative to venipuncture," said Eric Olson, founder and COO of Babson Diagnostics. "Babson's vision is for accessible, convenient, less invasive diagnostic testing that meets the needs of our local community, and we are excited to carry out this vision with UT Nursing students."
The AMEN project is led by Shalonda Horton, PhD, Clinical Assistant Professor at the UT Austin School of Nursing and funded by Austin Public Health to promote overall physical and mental wellbeing in the community. The project also organizes outreach events, where they offer BetterWay blood testing to underserved and vulnerable populations. Babson Diagnostics provides collection devices, laboratory testing, and supervision for the students throughout the event.
About BetterWay Blood Testing by Babson Diagnostics
BetterWay™ is blood testing reimagined-patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing.
Media Contact
Ray Young
512.694.0697
[email protected]
# # #
SOURCE: BetterWay Blood Testing
View the original press release on ACCESS Newswire
M.White--AT